1. A novel senolytic drug, seno-7284 ameliorates aging phenotype and age-related cardiometabolic diseases. (25th November 2020) Authors: Katsuumi, G; Shimizu, I; Suda, M; Yoshida, Y; Hayashi, Y; Nakao, M; Furuuchi, R; Hsiao, Y.T; Minamino, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the ageing-associated diseases and extended the lifespan. (25th November 2020) Authors: Suda, M; Shimizu, I; Katsuumi, G; Yoshida, Y; Hayashi, Y; Nakao, M; Ikegami, R; Furuuchi, R; Ozawa, T; Ozaki, K; Minamino, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P595Senescence-associated glycoprotein (SAGP) inhibits age-related endothelial dysfunction by the activation of mitophagy in vascular diseases. (28th August 2018) Authors: Suda, M; Shimizu, I; Yoshida, Y; Hayashi, Y; Katsuumi, G; Ikegami, R; Wakasugi, T; Nagasawa, A; Nakao, M; Furuuchi, R; Ujiie, A; Ozawa, T; Minamino, T Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗